HRMY FY 2023 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$582M+32.9% YoY

Gross Profit

$461M79.2% margin

Operating Income

$192M33.0% margin

Net Income

$129M22.1% margin

EPS (Diluted)

$2.13

Cash Flow

Operating Cash Flow

$219M

Free Cash Flow

$219M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$811M

Total Liabilities

$344M

Stockholders' Equity

$467M

Cash & Equivalents

$312M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$582M	$438M	+32.9%
Gross Profit	$461M	$354M	+30.0%
Operating Income	$192M	$120M	+59.8%
Net Income	$129M	$181M	-29.0%